Student pricing is available for eligible university email holders. View plans

NextSprints
NextSprints Icon NextSprints Logo
⌘K
Product Design

Master the art of designing products

Product Improvement

Identify scope for excellence

Product Success Metrics

Learn how to define success of product

Product Root Cause Analysis

Ace root cause problem solving

Product Trade-Off

Navigate trade-offs decisions like a pro

All Questions

Explore all questions

Meta (Facebook) PM Interview Course

Practice Meta-focused PM cases

Amazon PM Interview Course

Practice Amazon-focused PM cases

Apple PM Interview Course

Practice Apple-focused PM cases

Google PM Interview Course

Practice Google-focused PM cases

Microsoft PM Interview Course

Practice Microsoft-focused PM cases

All Courses

Explore all courses

1:1 PM Coaching

Practice in a one-to-one session

Resume Review

Narrate impactful stories via resume

Guides Pricing
nextsprints logo

Not a member?

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement.

nextsprints logo

Register to continue.

Login with Google Login with LinkedIn

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement .

Company focus

Vayyar

How can we explain the sudden 25% drop in accuracy rates for Vayyar's breast cancer screening technology observed in clinical trials during the last two weeks?

Prepared by NextSprints

15 mins
Report an error
Problem Solving Data Analysis Technical Understanding Healthcare Medical Devices Artificial Intelligence Root Cause Analysis Product Troubleshooting AI Diagnostics Clinical Trials Medical Technology
Product Management Root Cause Analysis Question: Investigating sudden accuracy drop in medical AI technology

Introduction

The sudden 25% drop in accuracy rates for Vayyar's breast cancer screening technology during clinical trials is a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root cause while considering both short-term and long-term implications for the product and company.

Framework overview

This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.

Step 1

Clarifying Questions (3 minutes)

  • Looking at the timing, I'm thinking there might have been a recent software update. Has there been any change to the screening algorithm or software in the past month?

Why it matters: Software changes could directly impact accuracy rates. Expected answer: Yes, a minor update was pushed two weeks ago. Impact on approach: If confirmed, we'd focus on rollback options and code review.

  • Considering the specificity of the drop, I'm wondering about the sample size. How many screenings were conducted in the last two weeks compared to previous periods?

Why it matters: A smaller sample size could lead to statistical anomalies. Expected answer: Sample size remained consistent at about 500 screenings per week. Impact on approach: If sample size is consistent, we'd rule out statistical variance.

  • Given the nature of clinical trials, I'm curious about the patient demographics. Has there been any change in the patient population being screened?

Why it matters: Different demographics could affect screening accuracy. Expected answer: No significant changes in patient demographics. Impact on approach: If confirmed, we'd focus on technical or procedural issues rather than patient factors.

  • Thinking about the screening process, I'm wondering if there have been any changes in the clinical trial protocols or procedures?

Why it matters: Procedural changes could affect how the technology is applied. Expected answer: No changes to protocols, but new technicians were trained recently. Impact on approach: If new technicians are involved, we'd investigate training and application consistency.

Subscribe to access the full answer

Image of author NextSprints

NextSprints

Updated Mar 29, 2025